Navigation Links
Yaz Settlement Funding News: 10K Cases Still Not Settled
Date:10/22/2013

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- Legal-Bay, The Lawsuit Settlement Funding Company, reported today that there still remains close to 10,000 Yaz and Yasmin Birth Control lawsuits still active in the court system.  Although it has been widely reported that Bayer Healthcare Pharmaceuticals Inc. have settled thousands of Yaz and Yasmin suits for over $1Bil at this point, and the average settlement amount for those cases were approximately $220K, there still remains many women victims patiently waiting for their money. 

(Logo: http://photos.prnewswire.com/prnh/20131022/PH01370LOGO )

However, Legal-Bay Funding –which is a mass tort plaintiff advocate firm assisting individuals with receiving lawsuit cash advances today on their suit prior to settlement- believes that the average settlement amount may be slightly higher going forward.  "It seems to us that we are starting to see higher settlement amounts where injuries are more severe; some of our clients have settled some of their cases close to $500K," said Patty Kirby, Head of Client Relations at Legal-Bay.  "With the recent delays in clients receiving funds, we have been getting an influx of Yaz lawsuit funding applications to our Yaz and Yasmin web page," added Ms. Kirby.  http://lawsuitssettlementfunding.com/yaz-yasmin-lawsuit-settlement-funding.php

Legal-Bay reports that many of their clients are frustrated that the settlements have not come faster, especially now that the holiday season is approaching.  Legal-Bay has been active assisting women who have been injured by both Yaz and Yasmin; as well as other birth control products such as Ocella and NuvaRing with obtaining Pre-settlement lawsuit funding on their active case. 
'/>"/>

SOURCE Legal-Bay
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DePuy Hip Recall Settlement News: First Federal Trial To Begin This Week
2. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
3. $74 Million Settlement Reached Regarding Pricing of Cipro
4. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
5. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
6. Grant & Eisenhofer Represents Whistleblowers in Justice Dept. $257 Million Civil Settlement with Wyeth over Unlawful Marketing of Rapamune
7. North South Holdings Inc. Announces its First Settlement and License Agreement.
8. Transvaginal Mesh Settlement Funding Amounts Increased At Legal-Bay
9. New Study Shows Pharmaceutical Patent Settlements Netted $25.5 Billion in Savings for U.S. Health System
10. Stryker And DePuy Pinnacle Hip Lawsuit Settlement News Update
11. Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015  Astellas today announced topline results from ... and safety of intravenous (IV) and oral isavuconazole, ... for adults with candidemia and other invasive ... that the trial did not meet its primary ... isavuconazole-treated patients at the end of IV therapy ...
(Date:7/29/2015)... -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial ... Wednesday, August 5, 2015, after the close of U.S.-based financial ... will host a conference call to review the results beginning ... The press release and a live audio-only ... link that is posted on the home page and Investor ...
(Date:7/29/2015)... July 29, 2015 Unilife Corporation (NASDAQ: ... manufacturer and supplier of injectable drug delivery systems, ... of instant patch pumps for insulin. ... insulin pump that does not require filling or ... and pre-assembled like an insulin pen, only three ...
Breaking Medicine Technology:Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4
... 11, 2011 CrystalGenomics, Inc., a biopharmaceutical company with ... draft Clinical Study Report (CSR) from CG400549,s Phase I ... CG400549 is a potential first-in-class antibiotic candidate ... enzyme in generating bacterial membrane and has a novel ...
... Corporation (NASDAQ: LIFE ) announced today that ... all of the outstanding 3.25% Convertible Senior Notes due ... As of May 6, 2011 there was $350,000,000 in ... The redemption notice provided includes CUSIP Numbers: 46185RAL4 and ...
Cached Medicine Technology:CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 2Life Technologies Announces Redemption of 3.25% Convertible Senior Notes Due 2025 2
(Date:7/30/2015)... ... 30, 2015 , ... Between 2012 and 2014 HIV infection rates rose from ... on June 17th. Those untreated heroin use disorders share their needles and spread the ... needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to 23 percent ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... Administration (DEA) Acting Administrator Chuck Rosenberg’s announcement of the reinstitution of National Prescription ... Saturday, September 26, 2015 from 10:00 AM to 2:00 PM local time. On ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Tisch Cancer ... Designation , The Tisch Cancer Institute (TCI) at the Icahn School of Medicine ... TCI joins an elite group of 69 cancer institutions nationwide that have earned ...
(Date:7/30/2015)... , ... July 30, 2015 , ... InventHelp, ... Texas, has designed a personal-care device that makes it easy to apply lotion or ... eliminate the need for assistance when applying lotion or medication to the back, and ...
Breaking Medicine News(10 mins):Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... been characterized as the most materialistic generation in history: ... owning luxury handbags and the latest technology devices. ... of teen materialism. In fact, research suggests that parents ... therefore, highly materialistic parents and peers are likely to ...
... ... headquartered in Nashville must pay $19.4 million plus interest to the United States government after ... , ... 2010 -- United States District Court Judge William J. Haynes, Jr. issued an order on ...
... ... Center School of Medicine has designed a first-of-its-kind program to alleviate ... Track (FMAT), has been approved by the Liaison Committee for Medical ... will complete their training one year earlier than students in the ...
... ... a new effort by Congress to reduce pharmacy choices, arbitrarily set prices, ... program. FEHBP enrollees feel that OPM does a great job managing ... the program by forcing OPM to change FEHBP’s pharmacy benefits. This was ...
... for some patients with operable disease, review finds , ... for patients with operable non-small cell lung cancer, say ... meta-analysis of 34 studies involving almost 8,500 patients (and ... years was 64 percent for patients who had chemotherapy ...
... Tuesday, President Obama signed into law U.S. health care ... affect them, their families, and businesses. The ... 2006 legislation in Massachusetts requiring all adults in the ... mandate. A new article from The Milbank Quarterly ...
Cached Medicine News:Health News:Counteracting teens' logo lust 2Health News:Fresenius Medical Holdings, Inc. Ordered To Pay $19.4 Million For Fraudulent Medicare Claims 2Health News:Fresenius Medical Holdings, Inc. Ordered To Pay $19.4 Million For Fraudulent Medicare Claims 3Health News:Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution 2Health News:Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution 3Health News:Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution 4Health News:PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP 2Health News:Chemo May Boost Survival After Lung Cancer Surgery 2Health News:Massachusetts health care reform reviewed as a model for national plan 2
... Lensmeter is designed for fast and easy ... Auto mode, the readings are automatically held ... lenses are automatically detected. The sophisticated alignment ... lens. The TL-2000A has been designed with ...
The Kowa Pro-lll is Kowas' flagship camera....
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
Medicine Products: